Status:
RECRUITING
Transcutaneous Spinal Cord Stimulation for Chronic Low Back Pain
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
National Science Foundation Center for Disruptive Musculoskeletal Innovations
Conditions:
Chronic Low-back Pain
Eligibility:
All Genders
21-85 years
Phase:
NA
Brief Summary
As a leading cause of disability worldwide, chronic low back pain (cLBP) represents a significant medical and socioeconomic problem with estimated health care spending of $87 billion/annually. The eff...
Eligibility Criteria
Inclusion
- Low back pain
- Able to get in and out of chair unassisted
- No changes in medication within 2 weeks of study enrollment
- Stable dose of their medications within 2 weeks of study enrollment
Exclusion
- Body Mass Index (BMI) \> 28
- Hardware in the spine from prior surgeries
- Presence of epidural stimulation leads
- Presence of any additional neuromuscular pain unrelated to spinal condition
- Intolerance to any form of electrical stimulation, such as neuromuscular stimulation in the past
- Lack of perceived endurance to go through multiple experimental assessments in one day/complete the study which may take up to 3 hours
- Changes in medications within 2 weeks of study enrollment
- Moderate/severe depression (Beck Depression Inventory score \> 20)
Key Trial Info
Start Date :
August 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05265000
Start Date
August 1 2022
End Date
June 1 2026
Last Update
February 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco VA Medical Center
San Francisco, California, United States, 94121